Clearmind Medicine Inc. (CMND) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Vancouver, BC, 加拿大. 现任CEO为 Adi Zuloff-Shani.
CMND 拥有 IPO日期为 2022-11-15, 4 名全职员工, 在 NASDAQ Capital Marke, 市值为 $88.83K.
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
